Based on the significant unmet need in Alzheimers disease as well as a number of indicative data points, we felt we had a responsibility to explore semaglutides potential, despite a low likelihood of success, Martin Holst Lange, chief scientific officer at Novo Nordisk said in a press release
While many reviewers praise the communication, the negative reviews paint a different picture
Novo Nordisk may attempt to mitigate the impact from off-patent competition by protecting their share of Wegovy by enhancing weight-management services, or migrating patients from semaglutide to newer, patent-protected AOMs, including offering an oral version of semaglutide, effectively offering therapies with greater patient benefits
This story was originally published July 8, 2024
When to Take Berberine Because standard berberine supplements are not as bioavailable as some other supplementsin other words, your body doesnt absorb it as readilyits key to time your doses just right, especially if youre taking standard berberine HCl